TLR3 and early-onset autosomal dominant Alzheimer disease: Synthetic TLR3 ligand poly I:C is frequently used to investigate the innate immune responses in models of psychiatric and neurodegenerative disorders including schizophrenia, autism, Parkinson's disease and Alzheimer's disease.